Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mass spectrometry
MedTech
BD biosciences, diagnostics units move to Waters in $17.5B deal
For 2025, the to-be-combined company’s portfolios and its 16,000 total employees are expected to generate about $6.5 billion in sales.
Conor Hale
Jul 14, 2025 11:09am
Roche to bring mass spec to routine labs with new CE Mark
Dec 18, 2024 10:08am
GV, Sanofi drive preclinical British biotech to $100M series B
Apr 28, 2022 2:00am
Charles River Labs deals with SAMDI to boost discovery tech
Jan 28, 2022 12:58pm
MOBILion Systems nets $60M for mass spectrometry tech
Jul 13, 2021 3:10pm
Researchers develop COVID test using atom-thick graphene sheets
Jun 17, 2021 2:05pm
